4 Results for "

anti-hypertrophic

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "anti-hypertrophic" in MCE Product Catalog:

9
9 Publications Verification
Cat. No.: HY-N0738
CAS No.: 4136-37-2
Stachydrine hydrochloride is the major active constituent of Leonurus artemisia, which is a potential therapy for cardiovascular diseases . Stachydrine can inhibit the NF-κB signal pathway. Anti-hypertrophic activities .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-143248
CAS No.: 2770300-35-9
Purity:  99.48%
KR-39038 is an orally active and potent GRK5 (G protein-coupled receptor kinase 5) inhibitor, with an IC50 of 0.02 μM. KR-39038 significantly inhibits angiotensin II-induced cellular hypertrophy through suppression of HDAC5 pathway in neonatal cardiomyocytes. KR-39038 shows profound anti-hypertrophic effects and improved cardiac function. KR-39038 can be used for heart failure research .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-168438
CAS No.: 930856-19-2
Target:  

EGFR Akt ERK

Research Areas:  

Cardiovascular Disease

ERBB agonist-1 is a ERBB4 agonist with an EC50 of 10.5 μM. ERBB agonist-1 enhances NRG1-induced ERBB4 homodimerization and activates the PI3K/Akt and MAPK/ERK signaling pathways. ERBB agonist-1 acts as a cell survival promoter, anti-hypertrophic agent, anti-fibrotic agent, and cardioprotective agent. ERBB agonist-1 is applicable to the research of heart failure .
loading...
    loading...
Cat. No.: HY-128326
CAS No.: 2362525-64-0
Target:  

MAP3K

Research Areas:  

Cardiovascular Disease

ZAK-IN-1 is an orally active and selective selective leucine-zipper and sterile‑α motif kinase (ZAK) inhibitor with IC50 of 4 nM and KD of 8 nM. ZAK-IN-1 exhibits excellent selectivity against a panel of 403 wild-type kinases. ZAK-IN-1 blocks p38/GATA-4 and JNK/c-Jun signaling and shows promising anti antihypertrophic cardiomyopathy (HCM) efficacy. ZAK-IN-1 can be used for the study of HCM .
loading...
    loading...